Chembio applies for CLIA waiver for HIV test
This article was originally published in Clinica
Executive Summary
Chembio Diagnostics has submitted study data to the US FDA as part of an application for a CLIA waiver for its diagnostic test for HIV. The information is part of an amendment to the firm's 2006 submission to the Center for Devices and Radiological Health division of the agency.